Oncology firm Constellation Pharmaceuticals Inc. (Nasdaq: CNST) is set to be acquired by MorphoSys AG (Nasdaq: MOR), a German drugmaker with a U.S. headquarters in Boston, for $1.7 billion in cash. Constellation shares surged by nearly 67% on the news.
Read More
